What is the current Omega-3 API market size?

The current Omega-3 API market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Omega-3 API market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Omega-3 API market?

Key drivers include growing health awareness and rising demand for pharmaceutical and dietary supplement applications.

What are the major challenges facing the Omega-3 API market?

Challenges include fluctuating raw material prices and stringent regulatory requirements.

Which regions are leading the Omega-3 API market?

North America and Europe are currently leading the market due to high demand and established infrastructure.

Who are the top companies in the Omega-3 API market?

Top companies include DSM, BASF, and Croda, which offer high-quality products and have strong global presence.

What future opportunities exist in the Omega-3 API market?

Future opportunities include expanding applications in animal nutrition and emerging markets with growing healthcare needs.

How is technology impacting the Omega-3 API market?

Advances in technology are improving production efficiency, reducing costs, and enabling the development of new products.

What is the current regulatory landscape for the Omega-3 API market?

The regulatory landscape is characterized by strict quality standards and increasing focus on sustainability and environmental impact.

What is the future outlook for the Omega-3 API market?

The future outlook is positive, with growing demand and emerging applications driving market growth and expansion.

Omega-3 API Market Intelligence Report 2026 — Updated June 2026

Omega-3 API by Application (Dietary Supplements, Fortified Food and Beverage, Infant Formula, Pharmaceuticals, Pet Foods, Others), by Types (Microalgal Derived, Non-microalgal Derived), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1435 million

CAGR: 6.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1435 million

CAGR: 6.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Omega-3 API Market Overview

The Omega-3 API market refers to the industry involved in the production and distribution of Omega-3 active pharmaceutical ingredients. The Omega-3 API market size is estimated to be around $1.5 billion in 2025, with a growth outlook that is expected to drive the market forward. As the demand for Omega-3 supplements continues to rise, the market forecast indicates a Compound Annual Growth Rate (CAGR) of 8% from 2026 to 2033, fueled by industry expansion into new regions and applications. The scope of this market encompasses various types of Omega-3 APIs, including EPA and DHA, and their applications in pharmaceuticals, nutraceuticals, and food supplements.

Loading chart…

The growth forecast of the Omega-3 API market is driven by macro drivers such as increasing consumer awareness of health and wellness, advancements in technology, and changing regulations. Key forces shaping the industry include technology shifts towards more efficient and sustainable production methods, regulations surrounding the use of Omega-3 APIs in pharmaceuticals and food supplements, and consumer behavior trends towards healthier lifestyles. The largest region for the Omega-3 API market is currently North America, while the fastest-growing region is expected to be Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to remain competitive.

Report Overview

Report Attribute	Details
Market size value in 2025	1.44 billion
Revenue forecast in 2033	2.50 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	DSM; BASF; EPAX; Golden Omega; Solutex; Omega Protein; Croda; Sinomega; GC Rieber; Polaris; Orkla Health; Kinomega; Skuny; Hofseth BioCare; KD Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Omega-3 API market is poised to experience significant growth, driven by increasing demand for pharmaceutical-grade Omega-3 products. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

The expanding applications of Omega-3 APIs in pharmaceutical and dietary supplement industries, coupled with advancements in extraction and purification technologies, are expected to drive the Omega-3 API market size and influence its growth forecast.

Growing consumer awareness about the health benefits of Omega-3 fatty acids, such as reduced heart disease risk and improved cognitive function, is fueling demand for high-quality Omega-3 API products, thereby contributing to the market's growth trajectory.

Restraints2 items

Stringent regulatory requirements and varying standards for Omega-3 API quality across different regions may hinder the market growth, as manufacturers must comply with multiple regulatory frameworks, increasing production costs and complexity.

Fluctuations in the global supply of fish oil and other raw materials, due to environmental factors and overfishing, can lead to price volatility and affect the stability of the Omega-3 API market, making it challenging for manufacturers to maintain consistent supply chains.

Opportunities2 items

The increasing adoption of vegetarian and vegan diets presents an opportunity for the development of alternative, non-animal-derived Omega-3 API sources, such as algae oil, which can cater to the growing demand for plant-based products and expand the Omega-3 API market size.

Emerging markets in Asia-Pacific and Latin America, with their large and growing populations, offer significant potential for the Omega-3 API market, driven by rising incomes, increasing health awareness, and unmet demand for nutritional and pharmaceutical products.

Challenges2 items

The Omega-3 API market faces intense competition, with numerous players operating globally, which can lead to pricing pressures and reduced profit margins for manufacturers, making it essential to differentiate products through quality, innovation, or strategic partnerships.

Ensuring the sustainability of Omega-3 API production, in terms of both environmental impact and social responsibility, is a significant challenge, as companies must balance business goals with the need to maintain eco-friendly practices and comply with sustainability standards.

Market Segmentation

Loading chart…

The Omega-3 API market can be segmented based on application, which includes pharmaceuticals, nutraceuticals, and food and beverages. The pharmaceuticals segment holds a significant share of the market, driven by the increasing demand for Omega-3 API in the production of prescription drugs. The nutraceuticals segment is also growing rapidly, owing to the rising awareness about the health benefits of Omega-3 fatty acids. The food and beverages segment is expected to witness moderate growth, as Omega-3 API is being increasingly used in the production of fortified foods and functional beverages. Understanding the Omega-3 API segmentation is crucial to determine the market size and growth prospects.

The Omega-3 API market can also be segmented based on types, which include EPA, DHA, and ALA. EPA and DHA are the most commonly used types of Omega-3 API, owing to their high bioavailability and efficacy in reducing inflammation and improving heart health. ALA is also gaining traction, driven by its increasing use in the production of vegetarian and vegan products. The types segment is expected to witness significant growth, as manufacturers are focusing on developing high-purity Omega-3 API products to cater to the growing demand from the pharmaceuticals and nutraceuticals industries. The market taxonomy of Omega-3 API is complex, with each type having its own set of subtypes and applications.

Omega-3 API Segmentation Breakdown10 items

Application

Dietary Supplements

Fortified Food and Beverage

Infant Formula

Pharmaceuticals

Pet Foods

Others

Types

Microalgal Derived

Non-microalgal Derived

Regional Insights

Loading chart…

The Omega-3 API market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and also the fastest-growing region, driven by increasing adoption of Omega-3 API in pharmaceutical and nutraceutical applications. Key drivers for Asia Pacific include government policies supporting the development of the pharmaceutical industry, significant investments in research and development, and a large demographics with a growing middle class.

In North America, key drivers include a mature ecosystem with established players, a high level of adoption of Omega-3 API in pharmaceutical applications, and significant investments in research and development. Europe is driven by a strong infrastructure for pharmaceutical manufacturing, a high level of adoption of Omega-3 API in pharmaceutical applications, and government policies supporting the development of the pharmaceutical industry. Latin America and Middle East & Africa are driven by a growing demographics with increasing demand for pharmaceutical and nutraceutical products, and investments in the development of the pharmaceutical industry.

The regional forecast indicates that the Omega-3 API market growth will be driven by increasing demand for pharmaceutical and nutraceutical products, and government policies supporting the development of the pharmaceutical industry. The adoption of Omega-3 API in pharmaceutical applications is expected to drive market growth, with Asia Pacific expected to be the fastest-growing region.

Competitive Landscape

The Omega-3 API market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Omega-3 API competitive landscape is driven by companies that balance these levers to maintain market share. Global players tend to focus on product innovation and certifications, while local companies often prioritize pricing and distribution.

Companies in the Omega-3 API market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. They also focus on technology, service model, channel strength, customization, and cost advantages to stay competitive. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their position in the market.

DSM: regional expansion

BASF: innovation pipeline

EPAX: premium pricing

Golden Omega: local manufacturing

Solutex: OEM tie-ups

Omega Protein: vertical integration

Key Omega-3 API Companies15 items

DSM

BASF

EPAX

Golden Omega

Solutex

Omega Protein

Croda

Sinomega

GC Rieber

Polaris

Orkla Health

Kinomega

Skuny

Hofseth BioCare

KD Pharma

Market Ecosystem

The Omega-3 API ecosystem encompasses a complex network of participants, spanning from upstream raw material suppliers to downstream end users. This ecosystem can be broadly categorized into three stages: upstream, midstream, and downstream, with value being created and captured through the interactions between technology providers, integrators, channels, and end users. A comprehensive value chain analysis is essential to understand the intricacies of this ecosystem.

Raw material suppliers — provide fish oil and other essential fatty acids

OEMs / manufacturers — produce Omega-3 API products

Technology providers — offer encapsulation and purification technologies

Distributors / channel partners — supply products to pharmaceutical and nutraceutical companies

Service providers / after-sales — offer testing and certification services

End users / buyers — pharmaceutical and nutraceutical manufacturers

Regulators/standards bodies — establish quality and safety standards

The flow of value within the Omega-3 API ecosystem is influenced by various control points, including regulatory approvals and industry standards. Dependency risks, such as input constraints and supply chain disruptions, can impact the availability of raw materials and finished products. Switching costs and partnerships between participants can also affect the ecosystem's dynamics. Furthermore, the ecosystem may differ by region due to variations in regulatory frameworks, market demand, and competitive landscapes, highlighting the need for a nuanced understanding of the Omega-3 API ecosystem.

Recent Industry Insights

The Omega-3 API industry trends have witnessed significant developments over the last 12-18 months, driven by growing demand for omega-3 fatty acids in pharmaceutical and nutraceutical applications. Recent partnerships between key players have focused on expanding production capacities and improving product quality. Notable mergers and acquisitions have also taken place, aiming to consolidate market share and enhance research and development capabilities.

Furthermore, several companies have launched new products and technologies, including more efficient extraction methods and novel delivery systems. Regulatory changes, such as updated guidelines for omega-3 API manufacturing, have also impacted the industry. A shift in consumer trends towards sustainable and eco-friendly products has led to increased adoption of algal oil-based omega-3 APIs. Additionally, funding rounds and expansions have been announced to support the growth of existing players and newcomers in the Omega-3 API industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Omega-3 API market. The market attractiveness is high due to the increasing demand for omega-3 fatty acids in pharmaceutical and nutraceutical applications. The competitive intensity is moderate, with a few key players dominating the market. The long-term outlook for the Omega-3 API market outlook is positive, driven by growing consumer awareness of health benefits and expanding applications in the pharmaceutical industry.

The innovation landscape is evolving, with ongoing research into new extraction methods and technologies. The demand–supply balance is expected to remain stable, with suppliers investing in capacity expansion to meet growing demand. However, key risk factors include regulatory changes and fluctuations in raw material prices. Overall, the market presents opportunities for growth and investment, particularly for companies that can innovate and adapt to changing consumer preferences.

11 items

1. Executive Summary

2. Omega-3 API Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Omega-3 API Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Omega-3 API Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Dietary Supplements

6.1.2. Fortified Food and Beverage

6.1.3. Infant Formula

6.1.4. Pharmaceuticals

6.1.5. Pet Foods

6.1.6. Others

6.2. Global Omega-3 API Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Microalgal Derived

6.2.2. Non-microalgal Derived

6.3. Global Omega-3 API Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Omega-3 API Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Omega-3 API Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Omega-3 API Market Competition by Key Manufacturers

8.1. Global Omega-3 API Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Omega-3 API: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. DSM

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BASF

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. EPAX

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Golden Omega

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Solutex

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Omega Protein

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Croda

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sinomega

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. GC Rieber

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Polaris

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Orkla Health

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Kinomega

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Skuny

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Hofseth BioCare

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. KD Pharma

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Omega-3 API Market

Figure 4: Global Omega-3 API Market: Drivers

Figure 5: Global Omega-3 API Market: Challenges

Figure 6: Global Omega-3 API Market: Trends

Figure 7: Global Omega-3 API Market: Opportunity

Figure 8: Global Omega-3 API Market: Restraint

Figure 9: Global Omega-3 API Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Omega-3 API Market Value (USD Million) By Region

Figure 15: Global Omega-3 API Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Omega-3 API Market Value (USD Million) By Region

Figure 23: Global Omega-3 API Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Omega-3 API Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Omega-3 API Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Omega-3 API Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Omega-3 API Market Value (USD Million) By Region

Table 10: Global Omega-3 API Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Omega-3 API Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Omega-3 API Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Omega-3 API Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: DSM Basic Information And Sales Area

Table 31: DSM. Products Portfolio

Table 32: BASF Basic Information And Sales Area

Table 33: BASF. Products Portfolio

Table 34: EPAX Basic Information And Sales Area

Table 35: EPAX. Products Portfolio

Table 36: Golden Omega Basic Information And Sales Area

Table 37: Golden Omega. Products Portfolio

Table 38: Solutex Basic Information And Sales Area

Table 39: Solutex. Products Portfolio

Table 40: Omega Protein Basic Information And Sales Area

Table 41: Omega Protein. Products Portfolio

Table 42: Croda Basic Information And Sales Area

Table 43: Croda. Products Portfolio

Table 44: Sinomega Basic Information And Sales Area

Table 45: Sinomega. Products Portfolio

Table 46: GC Rieber Basic Information And Sales Area

Table 47: GC Rieber. Products Portfolio

Table 48: Polaris Basic Information And Sales Area

Table 49: Polaris. Products Portfolio

Table 50: Orkla Health Basic Information And Sales Area

Table 51: Orkla Health. Products Portfolio

Table 52: Kinomega Basic Information And Sales Area

Table 53: Kinomega. Products Portfolio

Table 54: Skuny Basic Information And Sales Area

Table 55: Skuny. Products Portfolio

Table 56: Hofseth BioCare Basic Information And Sales Area

Table 57: Hofseth BioCare. Products Portfolio

Table 58: KD Pharma Basic Information And Sales Area

Table 59: KD Pharma. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Omega-3 API Market Value (USD Million) By Region

Table 65: Global Omega-3 API Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Omega-3 API Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.44 billion
Revenue forecast in 2033	2.50 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	DSM; BASF; EPAX; Golden Omega; Solutex; Omega Protein; Croda; Sinomega; GC Rieber; Polaris; Orkla Health; Kinomega; Skuny; Hofseth BioCare; KD Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Omega-3 API Segmentation Breakdown10 items

Application

Dietary Supplements

Fortified Food and Beverage

Infant Formula

Pharmaceuticals

Pet Foods

Others

Types

Microalgal Derived

Non-microalgal Derived

Regional Insights

Loading chart…

Competitive Landscape

DSM: regional expansion

BASF: innovation pipeline

EPAX: premium pricing

Golden Omega: local manufacturing

Solutex: OEM tie-ups

Omega Protein: vertical integration

Key Omega-3 API Companies15 items

DSM

BASF

EPAX

Golden Omega

Solutex

Omega Protein

Croda

Sinomega

GC Rieber

Polaris

Orkla Health

Kinomega

Skuny

Hofseth BioCare

KD Pharma

Market Ecosystem

Raw material suppliers — provide fish oil and other essential fatty acids

OEMs / manufacturers — produce Omega-3 API products

Technology providers — offer encapsulation and purification technologies

Distributors / channel partners — supply products to pharmaceutical and nutraceutical companies

Service providers / after-sales — offer testing and certification services

End users / buyers — pharmaceutical and nutraceutical manufacturers

Regulators/standards bodies — establish quality and safety standards

Recent Industry Insights

Analyst Overview

Table of Contents